JB Chemicals & Pharmaceuticals Sets Record Date for Amalgamation with Torrent Pharmaceuticals
J.B. Chemicals & Pharmaceuticals Limited has fixed the Record Date for the Scheme of Amalgamation involving its merger with Torrent Pharmaceuticals Limited. The company announced that shareholders will be determined based on this record date in relation to the share exchange ratio defined under the scheme, which was sanctioned by the National Company Law Tribunal (NCLT).The amalgamation involves J.B. Chemicals & Pharmaceuticals Limited (the Transferor Company) and Torrent Pharmaceuticals Limited (the Transferee Company). The scheme was sanctioned by the Hon'ble NCLT on July 6, 2026.
In accordance with the terms of the Scheme, Friday, July 17, 2026, has been designated as the Record Date. This date is crucial for determining the shareholders who are entitled to receive fully paid-up equity shares of Torrent Pharma as per the established share exchange ratio.
The scheme outlines a specific conversion rate for the merger:
* For every 100 fully paid-up equity shares of J.B. Chemicals, shareholders will receive 51 fully paid-up equity shares of Torrent Pharmaceuticals.
Details regarding the valuation and shares are as follows:
| Entity | Face Value (Per Share) | Shares in Exchange Ratio |
|---|---|---|
| J.B. Chemicals | Re. 1 each | 100 fully paid-up equity shares |
| Torrent Pharmaceuticals | Rs. 5 each | 51 fully paid-up equity shares |
The Record Date of July 17, 2026, ensures that all entitled shareholders can transact and participate in the amalgamation process according to the agreed terms.
JBCHEPHARM Stock Price Movement
Today, shares of JB Chemicals & Pharmaceuticals Limited edged higher to close at ₹2422 after gaining 1.26%, demonstrating solid momentum in the healthcare sector. The rally was capped by intraday trading but saw the stock touch its 52-week high on a day characterized by a total traded volume of 823,042 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.